Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Receivables (2021 - 2025)

Oncology Institute's Change in Receivables history spans 5 years, with the latest figure at -$641000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 110.39% year-over-year to -$641000.0; the TTM value through Dec 2025 reached $12.3 million, up 105.99%, while the annual FY2025 figure was $12.3 million, 105.99% up from the prior year.
  • Change in Receivables reached -$641000.0 in Q4 2025 per TOI's latest filing, down from $12.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $21.0 million in Q4 2022 to a low of -$11.8 million in Q3 2024.
  • Average Change in Receivables over 5 years is $2.0 million, with a median of $79000.0 recorded in 2023.
  • Peak YoY movement for Change in Receivables: soared 23200.0% in 2022, then crashed 33757.14% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $473000.0 in 2021, then surged by 4331.92% to $21.0 million in 2022, then plummeted by 99.58% to $87000.0 in 2023, then soared by 6989.66% to $6.2 million in 2024, then plummeted by 110.39% to -$641000.0 in 2025.
  • Per Business Quant, the three most recent readings for TOI's Change in Receivables are -$641000.0 (Q4 2025), $12.7 million (Q3 2025), and -$757000.0 (Q2 2025).